Related Experiment Video
Updated: Jun 18, 2025
04:20
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
5.2K
Control of Haemorrhage in Orthopaedic Trauma
Robert M Kenyon1, Jennifer L Leighton2
1Dalhousie University, Halifax, NS B3H 4R2, Canada.
Journal of Clinical Medicine
|July 27, 2024
Summary
This review covers modern strategies for managing severe bleeding in orthopaedic trauma, focusing on resuscitation and coagulation. It highlights tranexamic acid and emerging technologies for better patient outcomes.
Area of Science:
- Orthopaedic Surgery
- Trauma Management
- Hemorrhage Control
Background:
- Effective hemorrhage management is critical in orthopaedic trauma.
- Established prehospital and perioperative strategies require ongoing optimization.
- Understanding trauma-induced coagulopathy is essential for treatment.
Purpose of the Study:
- To review current practices in orthopaedic trauma hemorrhage management.
- To examine novel advancements and emerging technologies.
- To focus on resuscitation and coagulation in trauma patients.
Main Methods:
- Literature review of established and emerging techniques.
- Analysis of mechanisms of trauma-induced coagulopathy.
- Evaluation of the impact of tranexamic acid.
- Exploration of new technologies like endovascular interventions and advanced dressings.
Main Results:
- Tranexamic acid has significantly reduced blood loss in trauma patients.
- Emerging technologies show promise for future hemorrhage control.
- Optimized resuscitation and coagulation strategies improve patient care.
Conclusions:
- Continuous refinement of hemorrhage control practices is necessary.
- Emerging technologies are poised to revolutionize trauma care.
- Integrated approaches to resuscitation and coagulation are key.
Related Concept Videos
01:05Introduction to Hemostasis
6.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.9K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.8K
01:24Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
01:16Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K
01:28Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
01:24Blood Pressure Imbalances and Circulatory Shock
764
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
764